XML Financial LLC Boosts Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

XML Financial LLC increased its holdings in UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 20.2% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 2,716 shares of the healthcare conglomerate’s stock after buying an additional 456 shares during the period. XML Financial LLC’s holdings in UnitedHealth Group were worth $1,372,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. TimeScale Financial Inc. lifted its position in UnitedHealth Group by 276.9% during the third quarter. TimeScale Financial Inc. now owns 49 shares of the healthcare conglomerate’s stock valued at $25,000 after purchasing an additional 36 shares during the last quarter. Pflug Koory LLC boosted its holdings in UnitedHealth Group by 160.0% in the third quarter. Pflug Koory LLC now owns 52 shares of the healthcare conglomerate’s stock valued at $26,000 after acquiring an additional 32 shares in the last quarter. Urban Wealth Management LLC purchased a new stake in UnitedHealth Group in the second quarter worth about $29,000. Knott David M Jr purchased a new stake in UnitedHealth Group in the second quarter worth $29,000. Finally, Belmont Capital LLC lifted its holdings in shares of UnitedHealth Group by 294.1% during the third quarter. Belmont Capital LLC now owns 67 shares of the healthcare conglomerate’s stock valued at $34,000 after purchasing an additional 50 shares during the last quarter. Institutional investors own 86.31% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have weighed in on UNH shares. SVB Leerink reduced their price objective on shares of UnitedHealth Group from $625.00 to $618.00 and set an “outperform” rating for the company in a research note on Monday, October 17th. Royal Bank of Canada raised their price objective on shares of UnitedHealth Group from $588.00 to $592.00 and gave the company an “outperform” rating in a research note on Monday, October 17th. Credit Suisse Group raised their price objective on shares of UnitedHealth Group from $590.00 to $610.00 and gave the company an “outperform” rating in a research note on Wednesday, December 7th. Morgan Stanley reaffirmed an “overweight” rating and set a $587.00 price target on shares of UnitedHealth Group in a report on Wednesday, November 23rd. Finally, Raymond James downgraded shares of UnitedHealth Group from a “strong-buy” rating to an “outperform” rating and set a $615.00 price target on the stock. in a report on Monday, November 21st. Three analysts have rated the stock with a hold rating, twelve have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $599.39.

Insider Activity

In other news, EVP Erin Mcsweeney sold 450 shares of the business’s stock in a transaction on Wednesday, December 7th. The shares were sold at an average price of $542.30, for a total transaction of $244,035.00. Following the sale, the executive vice president now directly owns 8,736 shares of the company’s stock, valued at $4,737,532.80. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 0.40% of the company’s stock.

UnitedHealth Group Price Performance

NYSE UNH opened at $491.60 on Wednesday. The firm’s fifty day simple moving average is $518.45 and its two-hundred day simple moving average is $524.08. The company has a current ratio of 0.77, a quick ratio of 0.82 and a debt-to-equity ratio of 0.67. UnitedHealth Group Incorporated has a 12-month low of $436.51 and a 12-month high of $558.10. The firm has a market capitalization of $459.33 billion, a P/E ratio of 23.20, a P/E/G ratio of 1.36 and a beta of 0.73.

UnitedHealth Group (NYSE:UNHGet Rating) last released its quarterly earnings results on Friday, January 13th. The healthcare conglomerate reported $5.34 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.17 by $0.17. UnitedHealth Group had a net margin of 6.21% and a return on equity of 27.04%. The business had revenue of $82.79 billion for the quarter, compared to analyst estimates of $82.53 billion. During the same period in the previous year, the company earned $4.48 earnings per share. The business’s revenue for the quarter was up 12.3% on a year-over-year basis. Analysts forecast that UnitedHealth Group Incorporated will post 24.9 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 13th. Stockholders of record on Monday, December 5th were issued a dividend of $1.65 per share. This represents a $6.60 dividend on an annualized basis and a dividend yield of 1.34%. The ex-dividend date of this dividend was Friday, December 2nd. UnitedHealth Group’s dividend payout ratio (DPR) is presently 31.15%.

UnitedHealth Group Profile

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Featured Stories

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.